VaxGen, Inc.

S. San Francisco, CA; originally spun-off from Genentech to develop its candidate HIV vaccine; VaxGen is the largest shareholder in Celltrion, a S. Korean contract manufacturing joint venture; VaxGen was acquired by OXiGENE in late 2009